Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The World Health Organization (WHO), as part of its International Nonproprietary Names (INN) system, has recently made progress in developing and harmonizing the definition paragraphs that support the naming of cell-based substances.
Those efforts are reflected in a newly revised INN application form for cell therapy substances, which was officially approved during the 70th INN Consultation in April 2020.
That version is now mandatory for all new INN applications for gene therapy (GT), cell therapy (CT) and cell-based gene therapy (CGT) substances.
“
The work was initiated based on the large volumes of cell and gene therapy applications the WHO was seeing in relation to INN requests,” Massimo Dominici, medical oncology expert, CEO of Rigenerand, and a member of the WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations serving the INN Expert Group, told us.
World Health Organization selects ISCT journal Cytotherapy(R) to publish novel ATMP official nomenclature initiative pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.